Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Revenue

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹235 Cr₹198 Cr₹154 Cr₹140 Cr₹114 Cr

What is the latest Revenue of KILITCH DRUGS (INDIA) ?

The latest Revenue ratio of KILITCH DRUGS (INDIA) is ₹235 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹235 Cr
Mar2025₹198 Cr
Mar2024₹154 Cr
Mar2023₹140 Cr
Mar2022₹114 Cr

How is Revenue of KILITCH DRUGS (INDIA) Trending?

Years Revenue % Change
Mar2026 ₹235 Cr
18.74
Mar2025 ₹198 Cr
28.47
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr -

Compare Revenue of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹587.0 Cr 2.4% -5.4% -25% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹458,249.0 Cr 1.8% -1.6% 16.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr -1.2% 17.3% 38.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,891.0 Cr -2.3% -2% 33.6% Stock Analytics
CIPLA ₹115,927.0 Cr 0.2% 1.7% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹99,702.0 Cr 1.2% 3.6% -7% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

2.4%

-5.4%

-25%

SENSEX

-0.5%

1.3%

-4%


You may also like the below Video Courses